Multiple sclerosis and herpesvirus interaction

Imagem de Miniatura
Arquivos
art_SUMITA_Multiple_sclerosis_and_herpesvirus_interaction_2013.PDF (167.29 KB)
Citações na Scopus
20
Tipo de produção
article
Data de publicação
2013
Editora
ASSOC ARQUIVOS NEURO- PSIQUIATRIA
DOI
Indexadores
SciELO
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Autores
OLIVAL, Guilherme Sciascia do
LIMA, Bruna Mendonca
SERAFIM, Vitor
THOMAZ, Rodrigo Barbosa
CAVENAGHI, Vitor Breseghello
TILBERY, Charles Peter
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
ARQUIVOS DE NEURO-PSIQUIATRIA, v.71, n.9B, p.727-730, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Multiple sclerosis is the most common autoimmune inflammatory demyelinating disease of the central nervous system, and its etiology is believed to have both genetic and environmental components. Several viruses have already been implicated as triggers and there are several studies that implicate members of the Herpesviridae family in the pathogenesis of MS. The most important characteristic of these viruses is that they have periods of latency and exacerbations within their biological sanctuary, the central nervous system. The Epstein-Barr, cytomegalovirus, human herpesvirus 6 and human herpesvirus 7 viruses are the members that are most studied as being possible triggers of multiple sclerosis. According to evidence in the literature, the herpesvirus family is strongly involved in the pathogenesis of this disease, but it is unlikely that they are the only component responsible for its development. There are probably multiple triggers and more studies are necessary to investigate and define these interactions.
Palavras-chave
demyelinating disease, bmultiple sclerosis, herpesvirus
URI
https://observatorio.fm.usp.br/handle/OPI/5308
Referências
  1. Antony JM, 2004, NAT NEUROSCI, V7, P1088, DOI 10.1038/nn1319
  2. Ascherio A, 2001, JAMA-J AM MED ASSOC, V286, P3083, DOI 10.1001/jama.286.24.3083
  3. Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117
  4. De Bolle L, 2005, CLIN MICROBIOL REV, V18, P217, DOI 10.1128/CMR.18.1.217-245.2005
  5. DeLorenze GN, 2006, ARCH NEUROL-CHICAGO, V63, P839, DOI 10.1001/archneur.63.6.noc50328
  6. Dolei A, 2002, NEUROLOGY, V58, P471
  7. do Olival GS, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00172
  8. Giovannoni G, 2011, Int MS J, V17, P44
  9. Knox KK, 2000, CLIN INFECT DIS, V31, P894, DOI 10.1086/318141
  10. Levin LI, 2010, ANN NEUROL, V67, P824, DOI 10.1002/ana.21978
  11. Lunemann JD, 2007, J VIROL, V81, P6777, DOI 10.1128/JVI.00153-07
  12. Mameli G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044991
  13. Nora-Krukle Z, 2011, MED LITH, V47, P527
  14. Opsahl ML, 2005, BRAIN, V128, P516, DOI 10.1093/brain/awh390
  15. Opsahl ML, 2006, J NEUROL SCI, V240, P37, DOI 10.1016/j.jns.2005.08.014
  16. Perron H, 1997, P NATL ACAD SCI USA, V94, P7583, DOI 10.1073/pnas.94.14.7583
  17. Pirko I, 2012, PLOS ONE, V7, P1
  18. Pohl D, 2006, NEUROLOGY, V67, P2063, DOI 10.1212/01.wnl.0000247665.94088.8d
  19. Sanadgol N, 2011, NEW MICROBIOL, V34, P263
  20. Serra C, 2001, NEUROL SCI, V22, P171, DOI 10.1007/s100720170019
  21. Sotgiu S, 2002, NEUROLOGY, V59, P1071
  22. Voumvourakis KI, 2010, MAYO CLIN PROC, V85, P1023, DOI 10.4065/mcp.2010.0350
  23. Zivadinov R, 2006, NEUROL RES, V28, P262, DOI 10.1179/016164106X98134
  24. Zuvich RL, 2009, SEMIN IMMUNOL, V21, P328, DOI 10.1016/j.smim.2009.08.003

Coleções
Artigos e Materiais de Revistas Científicas - LIM/52
Artigos e Materiais de Revistas Científicas - IMT